Potential Therapies

This section looks at a selection of the therapies being developed or awaiting approval at present. We encourage a person to be cautious about any treatment or technique that has not yet been proven to be safe or effective in the treatment of MS.

Your neurologist or MS nurse will be able to give you more information to enable you to make a decision about your treatment options.

Chronic cerebrospinal venous insufficiency (CCSVI) is a condition thought to be caused by constrictions of large veins in the neck and chest.

Hyperbaric Oxygen Therapy is a form of treatment in which oxygen is administered under increased pressure in a specially designed chamber. Hyperbaric oxygen increases the oxygen content in the blood and in different body tissues.

There have been a few clinical triaIs examining the effect of hyperbaric oxygen in MS. Reviews of these studies indicate that there is no definite beneficial effect. Usually hyperbaric oxygen doesn't cause serious side-effects.

More information is available at the following websites:

Rituximab is a re-purposed drug, meaning it has been used to treat other conditions for some time and is now being explored as a treatment option for multiple sclerosis. It has had a license for many years to treat certain types of blood cancer and other auto-immune conditions and there are phase 2 clinical trials ongoing in MS currently. Current trial results seem to show that it is promising as a treatment for relapsing remitting MS. 

More information is available at the following websites:

Sativex is the world's first prescription medicine derived from the cannabis plant

There is a lot of interest currently in stem cell treatments for MS. Whilst these treatments are extremely promising, a lot more clinical and safety data is required. You can read more about the different types of stem cell treatment in our Briefing Document and Position Paper.

Top